Table 1. Clinical characteristics, lipoproteins, biomarkers, gene expression score and angiography results in all patients expressed as mean ± standard deviation or median and interquartile range, as appropriate.
| Characteristics | Results |
|---|---|
| Age (years) | 61.1±8.6 |
| Gender (% male) | 67% |
| % on lipid-lowering medications | 88.9% |
| % on aspirin therapy | 88.9% |
| % with hypertension | 83.3% |
| Total cholesterol (mg/dL) | 154.2±53.5 |
| LDL-cholesterol (mg/dL)† | 75.4±21.3 |
| HDL-cholesterol (mg/dL)‡ | 45.8±19 |
| Triglycerides (mg/dL) | 101.9 (67.2-165) |
| hsCRP (mg/dL)§ | 0.9 (0.4-2.3) |
| Lp-PLA2 (ng/mL)¶ | 148.2±44.5 |
| Gene expression score | 21.6±9.4 |
| % luminal stenosis | 58±16% |
| Fractional flow reserve | 0.88±0.1 |
†Low-density lipoprotein; ‡High-density lipoprotein; §high sensitivity C-reactive protein; ¶Lipoprotein-associated phospholipase A2